Relmada Therapeutics, Inc. RLMD Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s total assets?
- Relmada Therapeutics, Inc. (RLMD) reported total assets of $235.36M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s total assets changed year-over-year?
- Relmada Therapeutics, Inc.'s total assets increased by 750.3% year-over-year, from $27.68M to $235.36M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s total assets has grown at a -4.5% compound annual growth rate (CAGR), from $118.19M to $94M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.